ALLOVIR INC (ALVR) Stock Price, Quote, News and Overview
NASDAQ:ALVR - Nasdaq - US0198181036 - Common Stock - Currency: USD
ALVR Quote, Performance and Key Statistics
NASDAQ:ALVR (2/21/2025, 8:00:00 PM)
9.63
-0.2 (-2.03%)
The current stock price of ALVR is 9.63 USD. In the past month the price decreased by -5.5%. In the past year, price decreased by -40.01%.
ALVR Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 19.97 | 357.10B | ||
| AMGN | AMGEN INC | 15.29 | 162.72B | ||
| GILD | GILEAD SCIENCES INC | 23.85 | 137.00B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 1669.79 | 124.40B | ||
| REGN | REGENERON PHARMACEUTICALS | 15.34 | 76.56B | ||
| ARGX | ARGENX SE - ADR | N/A | 39.16B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 32.32B | ||
| BNTX | BIONTECH SE-ADR | N/A | 28.77B | ||
| ONC | BEIGENE LTD-ADR | N/A | 27.25B | ||
| NTRA | NATERA INC | N/A | 21.43B | ||
| BIIB | BIOGEN INC | 8.54 | 20.49B | ||
| SMMT | SUMMIT THERAPEUTICS INC | N/A | 16.31B |
Related stock screener links
About ALVR
Company Profile
AlloVir, Inc. engages in the research, development and commercialization of off-the-shelf VST therapies to prevent and treat severe viral-associated diseases. The company is headquartered in Waltham, Massachusetts and currently employs 112 full-time employees. The company went IPO on 2020-07-30. The company’s proprietary technology platforms leverage off-the-shelf, allogeneic, single- and multi-virus-specific T cells for patients with T cell deficiencies who are at risk from the life-threatening consequences of viral diseases. Its technology and manufacturing process enable the potential for the treatment and prevention of a spectrum of devastating viruses with each single allogeneic cell therapy. Its lead product candidate, posoleucel, is a multi-VST therapy that targets six viruses: adenovirus (BKV), cytomegalovirus (EBV), human herpesvirus 6 (HHV-6) and JC virus (JCV). Its proprietary VST manufacturing platform enables the rapid, robust and reproducible generation of single-virus and multi-virus specific cell therapeutic candidates for clinical use.
Company Info
ALLOVIR INC
1100 Winter Street
Waltham MASSACHUSETTS 02142 US
CEO: David Hallal
Employees: 8
Company Website: https://www.allovir.com
Investor Relations: https://ir.allovir.com/
Phone: 16174332605
ALLOVIR INC / ALVR FAQ
What is the stock price of ALLOVIR INC today?
The current stock price of ALVR is 9.63 USD. The price decreased by -2.03% in the last trading session.
What is the ticker symbol for ALLOVIR INC stock?
The exchange symbol of ALLOVIR INC is ALVR and it is listed on the Nasdaq exchange.
On which exchange is ALVR stock listed?
ALVR stock is listed on the Nasdaq exchange.
What is ALLOVIR INC worth?
ALLOVIR INC (ALVR) has a market capitalization of 48.54M USD. This makes ALVR a Nano Cap stock.
How many employees does ALLOVIR INC have?
ALLOVIR INC (ALVR) currently has 8 employees.
What are the support and resistance levels for ALLOVIR INC (ALVR) stock?
ALLOVIR INC (ALVR) has a support level at 9.27 and a resistance level at 9.68. Check the full technical report for a detailed analysis of ALVR support and resistance levels.
Should I buy ALLOVIR INC (ALVR) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of ALVR, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of ALVR, evaluating the profitability, health, valuation and growth aspects
- ALLOVIR INC (ALVR) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- ALLOVIR INC (ALVR) Sales and EPS estimates to see what analysts future expectations are.
- ALLOVIR INC (ALVR) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- ALLOVIR INC (ALVR) Insider and Institutional Ownership to learn about the owners and their transactions.
- ALLOVIR INC (ALVR) Stock Chart to make your own analysis
- ALLOVIR INC (ALVR) Latest news and press-releases to stay up to date.
Does ALLOVIR INC (ALVR) stock pay dividends?
ALVR does not pay a dividend.
When does ALLOVIR INC (ALVR) report earnings?
ALLOVIR INC (ALVR) will report earnings on 2025-03-13, after the market close.
What is the Price/Earnings (PE) ratio of ALLOVIR INC (ALVR)?
ALLOVIR INC (ALVR) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.67).
ALVR Technical Analysis
ALVR Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to ALVR. No worries on liquidiy or solvency for ALVR as it has an excellent financial health rating, but there are worries on the profitability.
ALVR Financial Highlights
Over the last trailing twelve months ALVR reported a non-GAAP Earnings per Share(EPS) of -1.67. The EPS increased by 25.78% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -81.77% | ||
| ROE | -82.73% | ||
| Debt/Equity | 0 |
ALVR Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 43% to ALVR. The Buy consensus is the average rating of analysts ratings from 6 analysts.